Yuwen Du

1.8k total citations
46 papers, 1.3k citations indexed

About

Yuwen Du is a scholar working on Molecular Biology, Cancer Research and Strategy and Management. According to data from OpenAlex, Yuwen Du has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 30 papers in Cancer Research and 3 papers in Strategy and Management. Recurrent topics in Yuwen Du's work include MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (15 papers). Yuwen Du is often cited by papers focused on MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (15 papers) and Circular RNAs in diseases (15 papers). Yuwen Du collaborates with scholars based in China, Japan and Taiwan. Yuwen Du's co-authors include Guoqiang Zhao, Wenqiao Zang, Xiaonan Chen, Yuanyuan Wang, Guojun Zhang, Huaqi Wang, Heying Chu, Yuanyuan Wang, Jianfang Feng and Ping Li and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and World Journal of Gastroenterology.

In The Last Decade

Yuwen Du

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwen Du China 24 952 760 123 104 79 46 1.3k
Wenqiao Zang China 26 1.2k 1.3× 1.0k 1.3× 157 1.3× 119 1.1× 86 1.1× 57 1.6k
Jihua Han China 13 659 0.7× 554 0.7× 101 0.8× 78 0.8× 53 0.7× 20 925
Lei Hu China 20 779 0.8× 483 0.6× 198 1.6× 103 1.0× 76 1.0× 38 1.2k
Haruka Shinohara Japan 22 1.2k 1.3× 890 1.2× 123 1.0× 72 0.7× 67 0.8× 32 1.5k
Kankan Wang China 23 1.4k 1.4× 451 0.6× 181 1.5× 84 0.8× 104 1.3× 82 1.9k
Haizhou Liu China 22 963 1.0× 705 0.9× 263 2.1× 177 1.7× 78 1.0× 69 1.4k
Chao Zhou China 21 726 0.8× 486 0.6× 131 1.1× 161 1.5× 61 0.8× 54 1.2k
Guang Zhang China 20 648 0.7× 365 0.5× 137 1.1× 64 0.6× 112 1.4× 49 985

Countries citing papers authored by Yuwen Du

Since Specialization
Citations

This map shows the geographic impact of Yuwen Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwen Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwen Du more than expected).

Fields of papers citing papers by Yuwen Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwen Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwen Du. The network helps show where Yuwen Du may publish in the future.

Co-authorship network of co-authors of Yuwen Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwen Du. A scholar is included among the top collaborators of Yuwen Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwen Du. Yuwen Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Bin, Yuwen Du, & Qi Fu. (2025). Supplier Encroachment Strategies on a Retail Platform With Strategic Consumers. Naval Research Logistics (NRL). 72(6). 879–899.
2.
Gao, Panpan, Haifeng Jiang, Yuwen Du, et al.. (2025). CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12+ microglia transformation. Acta Pharmacologica Sinica. 46(11). 3053–3070. 2 indexed citations
3.
Du, Yuwen, Taisuke Kajino, Yukako Shimada, Takashi Takahashi, & Ayumu Taguchi. (2025). Mir-494-3p enhances aggressive phenotype of non-small cell lung cancer cells by regulating SET/I2PP2A. Scientific Reports. 15(1). 15441–15441.
4.
Dai, Bin, et al.. (2024). Implications of unobservable promotion on distribution channel strategies in a retail platform. Transportation Research Part E Logistics and Transportation Review. 185. 103502–103502. 4 indexed citations
5.
Chen, Jiandong, et al.. (2023). An improved particle swarm optimization combined with double-chaos search. Mathematical Biosciences & Engineering. 20(9). 15737–15764. 4 indexed citations
6.
Wang, Zhuo, et al.. (2021). Feature selection using different evaluate strategy and random forests. 310–313. 2 indexed citations
7.
Feng, Long, Yunyun Ma, Ping Li, et al.. (2016). miR-15a induces cell apoptosis by targeting BCL2L2 and BCL2 in HPV-positive hypopharyngeal squamous cell carcinoma. Oncology Reports. 36(4). 2169–2176. 18 indexed citations
8.
Li, Ping, Juan Li, Rui Yang, et al.. (2015). Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer. Diagnostic Pathology. 10(1). 63–63. 22 indexed citations
9.
Guo, Wentao, Fei Wang, Yanjie You, et al.. (2015). miR-1291 targets mucin 1 inhibiting cell proliferation and invasion to promote cell apoptosis in esophageal squamous cell carcinoma. Oncology Reports. 34(5). 2665–2673. 31 indexed citations
10.
Chen, Shanshan, Ping Li, Rui Yang, et al.. (2015). microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer. Cancer Cell International. 15(1). 85–85. 35 indexed citations
11.
Zang, Wenqiao, Xuan Yang, Tao Wang, et al.. (2015). MiR-451 inhibits proliferation of esophageal carcinoma cell line EC9706 by targeting CDKN2D and MAP3K1. World Journal of Gastroenterology. 21(19). 5867–5876. 36 indexed citations
12.
Chen, Shanshan, Ping Li, Juan Li, et al.. (2015). MiR-144 Inhibits Proliferation and Induces Apoptosis and Autophagy in Lung Cancer Cells by Targeting TIGAR. Cellular Physiology and Biochemistry. 35(3). 997–1007. 98 indexed citations
13.
Du, Yuwen, Pingping Liu, Wenqiao Zang, et al.. (2015). BTG3 upregulation induces cell apoptosis and suppresses invasion in esophageal adenocarcinoma. Molecular and Cellular Biochemistry. 404(1-2). 31–38. 25 indexed citations
14.
Wang, Yuanyuan, Wenqiao Zang, Yuwen Du, Xiaonan Chen, & Guoqiang Zhao. (2015). The K167I variant of DNA polymerase β that is found in Esophageal Carcinoma patients impairs polymerase activity and BER. Scientific Reports. 5(1). 15986–15986. 3 indexed citations
15.
Li, Wentao, Wenqiao Zang, Pei Liu, et al.. (2014). MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumor Biology. 35(11). 10897–10904. 40 indexed citations
16.
Wang, Lei, Jianfang Feng, Xiaonan Chen, et al.. (2014). Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo. Cancer Cell International. 14(1). 71–71. 45 indexed citations
17.
Chen, Xudong, Guoqiang Zhao, Fuqing Wang, et al.. (2014). Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer. Tumor Biology. 35(11). 11081–11089. 31 indexed citations
18.
Zhang, Rui, Shangen Zheng, Yuwen Du, et al.. (2014). Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients. Diagnostic Pathology. 9(1). 61–61. 23 indexed citations
19.
Wu, Rui, Yue Tang, Wenqiao Zang, et al.. (2013). MicroRNA-128 regulates the differentiation of rat bone mesenchymal stem cells into neuron-like cells by Wnt signaling. Molecular and Cellular Biochemistry. 387(1-2). 151–158. 29 indexed citations
20.
Zang, Wenqiao, Yuanyuan Wang, Yuwen Du, et al.. (2013). Differential expression profiling of microRNAs and their potential involvement in esophageal squamous cell carcinoma. Tumor Biology. 35(4). 3295–3304. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026